Literature DB >> 9177961

Five-day versus ten-day treatment of acute otitis media with cefprozil.

D A Kafetzis1, H Astra, L Mitropoulos.   

Abstract

A randomized comparative clinical trial was conducted to investigate the possibility of decreasing the duration of treatment of acute otitis media by comparing the clinical outcome and safety of a five-day and a ten-day course of cefprozil. A total of 708 pediatric patients were enrolled in the study, 560 of whom were evaluable for efficacy. Cefprozil was found to be completely effective in 87.1% of cases after five days of treatment, and in 91.2% after ten days of treatment. Of 19 patients with three or more previous episodes of acute otitis media, ten patients in the ten-day treatment group had a 100% cure rate, while in the five-day group four experienced cure, three improvement, and two failure. A five-day course of treatment with cefprozil can be recommended only if children have no history of recurrent acute otitis media.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177961     DOI: 10.1007/BF01695632

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  THE TREATMENT OF ACUTE OTITIS MEDIA IN CHILDREN. II. A SECOND CLINICAL TRIAL.

Authors:  G B STICKLER; J B MCBEAN
Journal:  JAMA       Date:  1964-01-11       Impact factor: 56.272

2.  Antimicrobials in the treatment of acute otitis media. A second clinical trial.

Authors:  J W Bass; T M Cashman; A L Frostad; R M Yamaoka; R A Schooler; E P Dierdorff
Journal:  Am J Dis Child       Date:  1973-03

3.  Therapy of acute otitis media: myringotomy, antibiotics, or neither? A double-blind study in children.

Authors:  F L van Buchem; J H Dunk; M A van't Hof
Journal:  Lancet       Date:  1981-10-24       Impact factor: 79.321

4.  Comparative in vitro activity of the new oral cephalosporin BMY-28100.

Authors:  K E Aldridge; D D Schiro; C V Sanders
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

5.  Two versus seven days penicillin treatment for acute otitis media. A placebo controlled trial in children.

Authors:  K I Meistrup-Larsen; H Sørensen; N J Johnsen; J Thomsen; N Mygind; J Sederberg-Olsen
Journal:  Acta Otolaryngol       Date:  1983 Jul-Aug       Impact factor: 1.494

6.  A comparative study of clarithromycin and amoxycillin suspensions in the treatment of pediatric patients with acute otitis media.

Authors:  S J Coles; M B Addlestone; M K Kamdar; J L Macklin
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

7.  Five vs. ten days of therapy for acute otitis media.

Authors:  W A Hendrickse; H Kusmiesz; S Shelton; J D Nelson
Journal:  Pediatr Infect Dis J       Date:  1988-01       Impact factor: 2.129

8.  Bacteriology of acute otitis media: a new perspective.

Authors:  M A Del Beccaro; P M Mendelman; A F Inglis; M A Richardson; N O Duncan; C R Clausen; T L Stull
Journal:  J Pediatr       Date:  1992-01       Impact factor: 4.406

9.  Trial of three-day and ten-day courses of amoxycillin in otitis media.

Authors:  D M Chaput de Saintonge; D F Levine; I T Savage; G W Burgess; J Sharp; S R Mayhew; M G Sadler; R Moody; R Griffiths; S Griffiths; G Meadows
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-10

Review 10.  Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.

Authors:  D A Kafetzis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-10       Impact factor: 3.267

View more
  3 in total

1.  Management of acute otitis media.

Authors:  S Forgie; G Zhanel; J Robinson
Journal:  Paediatr Child Health       Date:  2009-09       Impact factor: 2.253

Review 2.  Short-course antimicrobial therapy of respiratory tract infections.

Authors:  David Guay
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 3.  Short-course antibiotics for acute otitis media.

Authors:  Anita Kozyrskyj; Terry P Klassen; Michael Moffatt; Krystal Harvey
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.